Pharmaceuticals

RNA Targeting Small Molecules Therapeutics Market Size Forecast: Revenue and CAGR by 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The RNA Targeting Small Molecules Therapeutics Industry Expected To Reach By 2029, Starting From 2025 Levels?

The RNA targeting small molecules therapeutics market size has experienced significant expansion in recent years. Its valuation is projected to rise from $6.1 billion in 2024 to $7.83 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 28.3%. This historical growth can be ascribed to elements such as drug discovery and development efforts, the increasing prevalence of RNA-related diseases, governmental and private financial backing, strong interest from the pharmaceutical industry, and successful applications of RNA therapeutics.

The market for RNA targeting small molecules therapeutics is projected to experience rapid expansion in the coming years. This market is anticipated to reach a valuation of $21.95 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 29.4%. Factors driving this growth during the forecast period include precision medicine and personalized therapies, the rise in RNA biomarker identification, an expanding RNA target spectrum, increasing funding and investments, and its application in rare diseases. Key trends identified for the forecast period encompass advancements in screening technologies, the dominance of antisense oligonucleotides, the development of small molecule RNA binders, the application of RNA therapeutics in neurological disorders, and gene editing with crispr-cas9.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12253&type=smp

What Are The Main Drivers Boosting The RNA Targeting Small Molecules Therapeutics Industry’s Expansion?

The rising number of cancer cases is anticipated to drive the expansion of the RNA-targeting small molecule therapeutics market moving forward. Cancer is a class of illnesses that can develop in nearly any bodily organ or tissue when abnormal cells reproduce uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. RNA-targeting small molecules, specifically designed and investigated to selectively target RNA molecules associated with cancer, are used to treat the disease. For instance, in January 2022, research published by the American Cancer Society, a US-based health organization, projected 609,360 cancer deaths and 1.9 million new cancer cases in the US for 2022. This amounts to approximately 1,670 fatalities each day. Therefore, the increasing incidence of cancer cases is fueling the growth of the RNA-targeting small molecule therapeutics market.

What Are The Primary Types Of Segments Analyzed In The RNA Targeting Small Molecules Therapeutics Market?

The rna targeting small molecules therapeutics market covered in this report is segmented –

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings

2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications

3) By Application: Drug Discovery, Oncology Research, Disease Identification

4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By mRNA (Messenger Ribonucleic Acid) Translation Modulators: Small Molecule Inhibitors, Enhancers Of Translation

2) By RNA (Ribonucleic Acid) Splicing Modification: Splicing Modulators, Antisense Oligonucleotides

3) By Direct RNA (Ribonucleic Acid) Targeting: RNA-Binding Small Molecules, RNA Aptamers

4) By Other Offerings: RNA Interference (RNAi) Therapeutics, Small Molecule Activators Of RNA Stability

What Trends Are Redefining The RNA Targeting Small Molecules Therapeutics Market Dynamics?

A notable and increasingly prevalent development within the RNA-targeting small molecule therapeutics market is the rise of strategic partnerships. Leading firms in the RNA-targeting small molecule therapeutics market are forming alliances to establish novel relationships, enabling multiple entities to co-create innovative products. An example of this is the collaboration in June 2022 between Otsuka Pharmaceutical Co. Ltd., a pharmaceutical manufacturer based in Japan, and xFOREST Therapeutics Co. Ltd., a Japan-based company specializing in drug discovery platform development. Through this collaboration, xFOREST will provide Otsuka with its proprietary Forest technology to further systemic small-molecule drug discovery research, specifically targeting RNA structures. Additionally, in April 2024, Ipsen, a biopharmaceutical firm from France, entered into a partnership with Skyhawk Therapeutics, a US-based clinical-stage biotechnology company known for its RNA-targeting small molecule therapeutics. This collaboration aimed to enable Ipsen to develop RNA-targeting small molecule drugs for rare neurological diseases, integrating diverse data sets to pinpoint and create small molecules capable of modulating RNA.

Which Industry Leaders Are Driving Innovation Across The RNA Targeting Small Molecules Therapeutics Market?

Major companies operating in the RNA targeting small molecules therapeutics market include F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

What Regional Growth Trends Are Shaping The RNA Targeting Small Molecules Therapeutics Market Outlook?

North America was the largest region in the RNA targeting small molecules therapeutics market in 2024. The regions covered in the RNA targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The RNA Targeting Small Molecules Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12253&type=smp

Browse Through More Reports Similar to the Global RNA Targeting Small Molecules Therapeutics Market 2025, By The Business Research Company

Cranes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cranes-global-market-report

Overhead Cranes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/overhead-cranes-global-market-report

Rubber Tired Gantry Crane Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rubber-tired-gantry-crane-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795